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Abnormalities associated with
progressive aortic vascular
dysfunction in chronic kidney disease
Omar Z. Ameer, Rochelle Boyd, Mark Butlin, Alberto P. Avolio and Jacqueline K. Phillips *
Faculty of Medicine and Health Sciences, The Australian School of Advanced Medicine, Macquarie University, Sydney, NSW,
Australia
Increased stiffness of large arteries in chronic kidney disease (CKD) has significant
clinical implications. This study investigates the temporal development of thoracic aortic
dysfunction in a rodent model of CKD, the Lewis polycystic kidney (LPK) rat. Animals
aged 12 and 18 weeks were studied alongside age-matched Lewis controls (total
n = 94). LPK rodents had elevated systolic blood pressure, left ventricular hypertrophy
and progressively higher plasma creatinine and urea. Relative to Lewis controls, LPK
exhibited reduced maximum aortic vasoconstriction (Rmax) to noradrenaline at 12 and
18 weeks, and to K+ (12 weeks). Sensitivity to noradrenaline was greater in 18-week-old
LPK vs. age matched Lewis (effective concentration 50%: 24 × 10−9 ± 78 × 10−10
vs. 19 × 10−8 ± 49 × 10−9, P < 0.05). Endothelium-dependent (acetylcholine)
and -independent (sodium nitroprusside) relaxation was diminished in LPK, declining
with age (12 vs. 18 weeks Rmax: 80 ± 8% vs. 57 ± 9% and 92 ± 6% vs. 70
± 9%, P < 0.05, respectively) in parallel with the decline in renal function. L-Arginine
restored endothelial function in LPK, and L-NAME blunted acetylcholine relaxation in
all groups. Impaired nitric oxide synthase (NOS) activity was recovered with L-Arginine
plus L-NAME in 12, but not 18-week-old LPK. Aortic calcification was increased in LPK
rats, as was collagen I/III, fibronectin and NADPH-oxidase subunit p47 (phox) mRNAs.
Overall, our observations indicate that the vascular abnormalities associated with CKD
are progressive in nature, being characterized by impaired vascular contraction and
relaxation responses, concurrent with the development of endothelial dysfunction, which
is likely driven by evolving deficits in NO signaling.
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Introduction
Individuals with chronic kidney disease (CKD) are at high risk of cardiovascular disease
(Kuznik et al., 2013) with renal failure and the accumulation of uraemic toxins proposed
to stimulate oxidative stress and inflammation that in turn may contribute to endothelial
dysfunction (Schiffrin et al., 2007). Endothelial dysfunction in CKD manifests primarily as
Abbreviations: CKD, Chronic kidney disease; NO, nitric oxide; LPK, Lewis polycystic kidney; SBP, systolic blood pressure;
NA, noradrenaline; PE, phenylephrine; ACh, acetylcholine hydrochloride; SNP, sodium nitroprusside; L-Arg, L-arginine;
L-NAME, Nω-nitro-L-arginine methyl ester hydrochloride; AUC, area under curve; SEM, standard error of mean; eNOS,
endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; SOD, superoxide dismutase.
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reduced endothelium-dependent vasodilation (Morris et al.,
2000). Reduced nitric oxide (NO) signaling is believed to be
one of the main factors involved in chronic renal failure–
induced endothelial dysfunction (Hasdan et al., 2002) and may
be caused by various mechanisms including decreased NO
synthesis, increased NO degradation due to oxidative stress
(Fuster et al., 1992; Quyyumi, 1998) or decreased NO-dependent
soluble guanylate cyclase protein activation and cyclic guanosine
monophosphate (cGMP) production (Giles et al., 2012).
Clinically significant changes in large artery viscoelasticity
resulting in altered reactivity, reduced compliance and increased
arterial stiffness have been reported among haemodialysis
patients (London et al., 1990) and damage to the large
capacitive arteries like the aorta is considered an important
factor contributing to increased morbidity and mortality in
end stage renal disease (ESRD) (Blacher et al., 1999; Pannier
et al., 2005; Guérin et al., 2008). This suggests a pivotal role for
the aorta in driving both systemic and/or organ dysfunction.
Specifically, aortic wall changes affect vessel compliance and
therefore pulse pressure. The transmission of this pulsatile energy
is associated with end organ damage (O’Rourke and Safar,
2005). Increased pulse pressure, remodeling and stiffness of large
arteries has been associated with the rate of change in renal
function (Ford et al., 2010; Briet et al., 2011) including changes
in glomerular filtration rate and microalbuminuria (Fesler et al.,
2007; Hermans et al., 2007), and likely therefore contributes
to the progression of CKD. Accordingly, aortic structure and
function, as a crucial component of the cardiovascular system,
can affect and be affected by kidney disease (Bakris et al., 2003;
Mitchell, 2008).
The Lewis polycystic kidney (LPK) rat is an autosomal
recessive model of cystic renal disease, arising from a mutation
in the nek8 gene (McCooke et al., 2012), and therefore a
form of nephronophthisis (NPHP9), which in rodents has a
phenotypic renal presentation resembling human autosomal
recessive polycystic kidney disease (Phillips et al., 2007; Trapp
et al., 2008). We have previously verified in the LPK rat aorta
features of arteriosclerosis, including vascular remodeling, and
calcification at 12 weeks of age, a time point where hypertension
is established and rats manifest impaired renal function (Ng et al.,
2011). Using tensile testing to assess the passive biomechanical
properties of the aorta, and pulse wave velocity as a surrogate
measure of arterial stiffness, we have evidence to indicate
these structural changes result in functional abnormalities
(Ng et al., 2011; Ameer et al., 2014), however no in-vitro
assessment of large artery function has been made, nor has the
relationship with ongoing deterioration in renal function been
determined.
In the present investigation, we therefore aimed to determine
if hypothesized changes in vascular contractility, endothelial-
dependent and independent-mechanisms, and integrity of
endothelial NO function in the LPK aorta were progressive in
nature, examining animals at both intermediate and late time
points in the disease process. We further examined other systems
potentially underlying aortic vascular dysfunction including
markers of stiffness, oxidative stress, calcification and systemic
NO levels.
Materials and Methods
Animals
Mixed sex 12 and 18 week old LPK and Lewis control rats were
used in this study. Animals from three specific cohorts were
used for the following analysis: (i) 12- and 18-week-old LPK
and Lewis rats (n = 8 per age and strain) were used for in-
vitro organ bath studies. Plasma analysis for urea, creatinine and
plasma nitrates were determined for this cohort; (ii) 12- and
18-week-old LPK and Lewis rats (n = 4 per age and strain)
were used for aortic mRNA analysis. Phenotypic data including
bodyweight, systolic blood pressure (SBP), heart, left ventricle
and kidney indices (tissue weight (g)/body weight (g) × 100%)
and plasma analysis for urea and creatinine was determined
for these animals. To facilitate tissue sharing and reduction
in animal usage, some data from animals in this cohort (SBP,
plasma urea and creatinine) contributed to another larger study
correlating these variables with anaemia measures in the LPK
model (Phillips et al., in press). (iii) 12- and 18-week-old LPK
(n = 9 each age), and 12- and 18-week-old Lewis rats (n = 16
and 12, respectively) were used for aortic Ca+2 content analysis.
A total of 94 rats were used overall. All animals were obtained
from the Animal Resource Center (Perth, WA, Australia) and
housed at Macquarie University (NSW, Australia). The rats were
allowed to acclimatize in the animal house facility under standard
12/12 light-dark cycle (20.5◦C) for at least 1 week prior to
the experiments. The rats were fed with normal rat chow and
water ad libitum. All experiments were approved by the Animal
Ethics Committee of Macquarie University and carried out in
accordance with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes (8th Edition, 2013).
Tail-cuff Plethysmography
Systolic blood pressure was measured using tail-cuff
plethysmography (IITC Life Science Inc., CA, USA) 1–2
days prior to euthanasia, as previously described (Phillips et al.,
2007). An average of 6 sequential measurements were taken after
acclimatizing the animal to the restrainer.
Animal Euthanasia and Plasma Collection
Prior to euthanasia, animals were fasted overnight with free
access to drinking water. Animals were then deeply anaesthetized
with 5% isoflurane in 100% O2 and decapitated. Trunk blood
samples were collected in pre-cooled EDTA-containing tubes and
centrifuged (4◦C at 3000 rpm for 5min). Plasma was separated
and stored at−80◦C until further use.
in-vitro Aortic Ring Preparation
After euthanasia, the thoracic aorta was removed and placed
in ice-cold Krebs solution (in mM: NaCl 118.2, KCl 4.7, CaCl2
2.5, MgSO4 1.2, KH2PO4 1.2, glucose 11.7, NaHCO3 25, and
EDTA 0.026) continuously aerated with carbogen (5% CO2+
95% O2). After clearing of adherent connective and adipose
tissue, an aortic ring 3–5mm in length was taken approximately
6mm caudal to the aortic arch. The segment was horizontally
mounted in an organ bath on 2 stainless steel hooks attached
to a metal holder (Radnoti LLC, CA, USA) and maintained in
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Kreb’s solution at 37.4◦C, pH 7.3–7.5, constantly bubbled with
carbogen. Rings were subjected to a 1 g (980mN) tension and
allowed to equilibrate for at least 40min. During the equilibration
period, Kreb’s solution in the chamber was changed every 15min
to avoid metabolite build-up and tension was readjusted to 1 g if
necessary as previously described (Ameer et al., 2010). Responses
were recorded isometrically via a force displacement transducer
connected to a PowerLab digital acquisition system and data was
acquired using LabChart Software (both ADInstruments, CA,
USA).
Drugs
Noradrenaline hydrochloride (NA), phenylephrine
hydrochloride (PE), acetylcholine hydrochloride (ACh), sodium
nitroprusside (SNP), L-arginine (L-Arg), Nω-nitro-L-arginine
methyl ester hydrochloride (L-NAME) were purchased from
Sigma-Aldrich (NSW, Australia). Drugs were made to a stock
solution in 0.9% saline and then diluted to the required working
concentration in Kreb’s solution prior to addition to the organ
bath or in the organ bath itself.
in-vitro Experimental Protocols
The following experimental protocols were performed
consecutively on one aortic ring from each rat, with at
least a 20min recovery period allowed between different drug
conditions:
Protocol I
Vascular contractility was assessed by generating concentration-
response curves to the α-adrenergic receptor agonist NA and
depolarization induced by potassium chloride (KCl), reflecting
aortic adrenergic and smooth muscle reactivity, respectively.
Cumulative concentration-responses to final bath concentrations
of 1×10−10–3×10−4MNA and 5–100mMKCl were performed.
Protocol II
Endothelium-dependent and -independent relaxation responses
were then assessed. Each ring was precontracted with 1µM
of the α1-adrenergic receptor agonist PE. Upon achieving
the maximum plateau response, endothelium-dependent
relaxation was assessed using cumulative concentrations
(1× 10−10 − 1× 10−4M) of ACh. Tissues were then washed
and following recovery (minimum 20min), the rings were
precontracted with PE and endothelium-independent relaxation
evaluated using 1×10−11–1×10−5M cumulative concentrations
of SNP.
Protocol III
The final experimental protocol was designed to assess
endothelial function and the integrity of components of the NO
pathway. In separate conditions, cumulative-responses to ACh
were recorded in aortic rings precontracted with PE (1µM),
preincubated for 20min with: (1) the nitric oxide synthase (NOS)
substrate, L-Arg (10mM) (Sato et al., 1996); (2) the non-selective
NOS inhibitor, L-NAME (10µM); (3) or a combination of both
L-Arg and L-NAME.
Time control experiments, comparing NA maximum
contractile response (Rmax) over the course of the experimental
protocol (on average 340min) were conducted to ensure viability
of the aortic rings.
Vascular Responses Data Analysis
Contractile force responses to NA and KCl were normalized to
the wet weight of the individual ring measured after completion
of the experiment, as previously described (Kauser et al., 1998;
Takahashi et al., 2003), to give a measure in N/g. Concentration-
response curves were fitted to a sigmoidal curve: Y = Lower
plateau + (Rmax- Lower plateau)/(1+10
(LogEC50-X)) where Y is
the force response and X the drug concentration. The 50%
effective concentration (EC50) was used to evaluate sensitivity
to vasoactive substances. The largest response induced by
the agonists (NA, KCl, ACh, and SNP) was considered the
Rmax and % responses were calculated relative to it. The area
under the cumulative concentration-response curve (area under
curve: AUC) was also determined for each respective agonist,
representative of the total vascular reactivity (Vedernikov et al.,
1997; Peinado et al., 1998). The differences between Rmax
response to ACh and that in the presence of L-NAME were
considered as the NO-dependent component of the ACh-
induced response (Paulis et al., 2008).
Plasma Assays
Plasma creatinine and urea levels were determined using
an IDEXX VetTest R© Chemistry Analyzer (IDEXX, NSW,
Australia).
Plasma NO−2 and NO
−
3 were determined using DetectX
R© NO
colorimetric detection kit (Arbor assays, MI, USA) following
the manufacturer’s instructions and as described previously
(Fujiwara et al., 2000). Briefly, the plasma was diluted 1:4 with
the assay buffer, and then passed through 10-kDa ultrafilters,
mixed with 25µl cofactor and 25µl nitrate reductase. After
the plasma mixture had been incubated at room temperature
for 5min to convert NO−3 to NO
−
2 , total NO was measured at
540 nm absorbance (iMark microplate reader BioRad, Japan) by
reaction with Greiss reagent (sulfanilamide and naphthalene-
ethylenediamine dihydrochloride). Amounts of NO−2 in the
plasma were estimated by a standard curve obtained from
enzymatic conversion of NaNO3 to NO
−
2 . Lastly, plasma
NO−3 was obtained by subtraction of total NO from NO
−
2
concentration.
Aortic Calcium Content
After euthanasia, the descending thoracic aorta was collected,
cleaned with saline and dried at 40◦C in an oven for
40min. To measure aortic calcium content, tissue was then
incubated in 1M HCl for 72 h and calcium was determined
colorimetrically using 100µM o-cresolphthalein complexone in
270mM aminomethylpropanol buffer (pH 10.0) with 5.2mM
8-hydroxyquinolone added to complex magnesium as per the
work of Sutliff et al. (2011). Absorbance was measured at
575 nm (U700 spectrophotometer, Beckman Coulter, CA, USA).
Aortas were dried after extraction and weighed, and results
were expressed asµmole per gram of dry weight (Sutliff et al.,
2011).
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RNA Isolation, Reverse Transcription, and
Quantitative Polymerase Chain Reaction
After euthanasia, the descending thoracic aorta was dissected
and total RNA was extracted using an RNA isolation kit (Master
Pure RNAPurification Kit, Epicenter Biotechnologies,WI, USA),
according to the manufacturer’s protocol. RNA concentration
was determined using a Nanodrop 2000 spectrophotometer
(Thermo Fisher Scientific, VIC, Australia) and first-strand cDNA
was synthesized from total RNA (2.5µg, average 260/280 ratio
2 ± 0.1) using the Affinity Script TM QPCR cDNA Synthesis
Kit (Stratagene, Agilent Technologies, CA, USA) using random
primers (100 ng/µl), as per the manufacturer’s instructions.
Real time quantitative polymerase chain reaction (qPCR) was
performed using 1µl of cDNA mix in a 25µl reaction with each
forward and reverse primer (300–600 nM final concentration;
Table 1) using Brilliant II SYBR R© Green qPCR master mix
as provided by the manufacturer (Stratagene). Conditions for
qPCR (40 cycles) were as follows: 95◦C for 30 s, 60◦C for 1min,
then 72◦C for 1min. Each reaction was performed with three
replicates and the average taken for each animal, with n-values
representing the number of animals.
Cycle threshold (Ct) values represent PCR cycle number
at which fluorescence emission data exceeded a threshold
limit, with a lower number representing a higher level
of expression. 1Ct values were calculated by normalizing
to tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, zeta peptide (YWHAZ) as an endogenous
control, predetermined for stability using the geNorm reference
gene selection kit as per the manufacturer’s instructions (Primer
Design Ltd, Southampton, UK). 1Ct values were compared for
significant differences between ages and strain as detailed below,
which drove subsequent calculation of fold variation between the
chosen reference (defined as a set value of 1) and other groups
using the 2−(11Ct) method (Livak and Schmittgen, 2001), with
range values determined using the formula 2−(11Ct+ SEM1Ct).
Calculation of range values was similarly applied to the chosen
reference, providing range values around the set value of 1.
Statistical Analysis
Results are expressed as mean ± standard error of mean (SEM).
Analysis was conducted using IBM Statistical Package for the
Social Sciences (SPSS; v20, IL, USA) and Prism v 6.0a (GraphPad
Software Inc. CA, USA). Preliminary analysis of data to identify
strain and treatment effects was undertaken using a univariate
general linear model (GLM) against the fixed factors of age and
strain with gender entered as a covariate. A Brown-Forsythe
test was used to determine if there were any differences in the
variance, and if so, the data was log-transformed before statistical
analysis. Unless otherwise stated, age and strain effects were not
influenced by gender (P > 0.05). Results were evaluated by Two-
Way ANOVA followed by Bonferroni post-hoc analysis, driven by
the major effects and/or interactions.
Results
Body Weight, Cardiac Hypertrophy, Blood
Pressure, and Renal Function
Baseline animal phenotypic data is presented in Table 2. LPK
animals weighed significantly less than Lewis at both ages, with
females weighing less than males in both strains. Heart index, left
ventricular index, kidney weight index and SBP were greater in
the LPK than Lewis at both ages studied, but did not change with
age within either the LPK or control strain. Plasma creatinine
and urea were markedly elevated in the LPK compared with age-
matched Lewis, and showed an age-dependent increase within
the LPK strain.
Vascular Aortic Ring Contractility
Time control experiments showed that the aortic rings
maintained their vascular response over the course of the
experiment [NA maximum contractile response (Rmax) values at
the start and finish of the experiment were: 12 weeks 3.4± 0.7 vs.
2.8 ± 0.7 contraction (N/g), 18 weeks 2.4 ± 0.3 vs.2.2 ± 0.5 N/g,
P > 0.05 for all].
Contraction concentration-response curves to NA were
blunted in the LPK relative to aged-matched Lewis, with an age
effect (reduction) evident in Lewis but not LPK rats (Figure 1A).
This was reflected in a lower Rmax for LPK at both 12 and 18
weeks vs. age matched controls, and an age effect for Rmax in
the Lewis (Table 3). AUC for NA was also significantly less in
the LPK rats at 18 weeks vs. age matched controls (P = 0.01;
Table 3). There was a leftward shift in the % contraction response
TABLE 1 | Primers for real-time reverse quantitative polymerase chain reaction.
Gene Forward primer Reverse primer Size (bp) Accession no
Collagen I TGGCTGCACGAGTCACACCGG GGGAGGTCTTGGTGGTTTTG 68 NM_053304.1 (Keane et al., 2007; Mizuno et al., 2009)
Collagen III GGTCAGCCAGGTCGAGACGGATC TGGGGCACCAGGAGAACCATTTT 72 NM_032085.1
Fibronectin AGAGTGAGCCCCTGATTGGGAGGA TCACCCTGCAAACCAACGGTCG 70 L00191
eNOS GGATCCAGTGGGGGAAACTG TGGCTGAACGAAGATTGCCT 123 NM_021838
iNOS TGGCCTCCCTCTGGAAAGA GGTGGTCCATGATGGTCACAT 95 U03699 (Edwards et al., 2004)
SOD CCACTGCAGGACCTCATTTT CACCTTTGCCCAAGTCATCT 218 NM_017050 (Duong et al., 2008)
p47 (phox) CCAGCTCCCAGGTGGTATGAT TCTTCACCTGGCTGTCATTG 178 AY029167 (Masamune et al., 2008)
Primers were designed and/or verified using the NBCI/ Primer-BLAST database (http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome). Testing included
assessment of secondary annealing, mismatching or partial annealing to sequences other than the intended target. Correct product size for each primer set was confirmed by visualization
of amplicons on Safegreen stained agarose gels. Primers provided in 3′–5′ sequence. Amplicon size is provided in base pair (bp). eNOS, endothelial nitric oxide synthase, iNOS, inducible
NOS, SOD, superoxide dismutase, p47 (phox), NADPH oxidase subunit p47 (phox).
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relationship to NA in the LPK aorta at both age points compared
to Lewis rats (Figure 1C), but this was seen as a significant
difference in the EC50 in the 18-week-old age group (Table 3),
suggestive of a progressive increase in sensitivity toward the
α-adrenergic agonist.
TABLE 2 | Body and tissue weights, systolic blood pressure and renal
function variables.
Parameter 12-week-old 18-week-old
Lewis LPK Lewis LPK
BW (g) 286.0± 41.6 185.0±18.7a 330.0± 55.9b 199.2±26.4a*
HI (%) 0.3± 0.01 0.5±0.02a 0.3± 0.02 0.5±0.02a*
LVI (%) 0.2± 0.01 0.4±0.04a 0.2± 0.01 0.4±0.02a*
KI (%) 0.9± 0.01 9.6±0.43a 0.8± 0.01 9.1±0.34a*
SBP (mmHg) 129.7± 2.0 204.6±10.4a 119.2± 3.5 215.7±3.5a*
PCr (µmol/L) 19.3± 1.8 42.5±3.5
a 21.2± 0.7 110.0±6.2a*,b*
Urea (mmol/L) 8.1± 0.2 26.3±2.0a 6.9± 0.3 39.7±1.4a*,b*
Results are expressed as mean ± SEM.
aP < 0.05 between 12 weeks Lewis and LPK.
a*P < 0.05 between 18 weeks Lewis and LPK.
bP < 0.05 between 12 and 18 weeks Lewis.
b*P < 0.05 between 12 and 18 weeks LPK.
Data was obtained from animals used for aortic PCR gene expression analysis (n-values
as detailed for cohort (ii). BW, body weight; HI, heart index; LVI, left ventricle index; KI,
kidney index; SBP, systolic blood pressure; PCr , plasma creatinine; LPK, Lewis polycystic
kidney rat.
Maximal aortic smooth muscle contraction to the
depolarizing signals of high K+ was significantly lower in
LPK compared with Lewis and progressive age-dependent
changes were evident in both strains (Figure 1B). LPK Rmax and
AUC values for KCl were lower than controls at 12 weeks but
not 18 weeks. A progressive decline in these values was seen with
age in Lewis rats only (Table 3). Contraction responses to KCl
expressed as a % were rightward shifted in the 18-week-old LPK
relative to age-matched Lewis and younger LPK (Figure 1D),
and a higher EC50 value was also observed in these animals
(Table 3).
Vascular Aortic Ring Relaxation
Aortic endothelium-dependent relaxation curves were blunted in
the LPK compared to age-matched Lewis (Figure 2A). The 18-
week-old LPK Rmax values for ACh were significantly less than
age-matched Lewis and 12-week-old LPK rats (Table 3). EC50
was lower in the 18-week-old LPK compared to controls, with
the Lewis rats having an age-dependent decrease in endothelium-
dependent relaxation in terms of EC50 values (Table 3).
Aortic endothelium-independent relaxation curves in
response to SNP were rightward-shifted in the LPK and 18-
week-old Lewis (Figure 2B). EC50 values in 12-week-old LPK
rats were greater than age matched Lewis rats and Rmax was
significantly reduced in 18-week-old LPK vs. Lewis rats of the
same age and 12-week-old LPK (Table 3). AUC for SNP also
showed an age related decline in the LPK.
FIGURE 1 | Panels illustrate aortic contractile responses to
cumulative additions of noradrenaline (NA; A,C) and potassium
chloride (KCl; B,D) expressed as absolute force per aortic ring weight
(N/g; A,B) and relative % of the vasoconstrictor (contraction %; C,D).
Aortic contraction to NA was depressed in the Lewis polycystic kidney (LPK)
rats at both ages, and showed an age related increase in sensitivity, while
aortic contraction to KCl progressively declined with age. Significant
differences between response curves are indicated P < 0.05 Lewis vs. LPK
at (a) 12 weeks of age and (a*) 18 weeks of age. P < 0.05 for age effect in (b)
Lewis and (b*) LPK.
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TABLE 3 | Parameters describing the concentration-response curve to various pharmacological agents in 12 and 18 weeks of age Lewis and LPK aortic
rings.
EC50 (M) (%) Rmax AUC
Lewis LPK Lewis LPK Lewis LPK
12-WEEK-OLD
NA 10.8× 10−8 ± 59.1×10−9 13.3× 10−9 ± 55.2×10−10 4.4± 0.6N/g 1.3± 0.2N/ga 17.7± 2.7N/g 6.3±0.7N/ga
KCl 8.5± 1.6 13.4± 2.6 3.7± 0.6N/g 1.9± 0.4N/ga 3.1± 0.4N/g 1.5±0.3N/ga
ACh 49.1× 10−9 ± 14.4×10−9 83.7× 10−8 ± 37.7×10−8 91± 3% 80± 8% 253± 19% 187±27%
SNP 32.7× 10−10 ± 62.6×10−11 19.9× 10−9 ± 90.0×10−10a 99± 0.4% 92± 6% 286± 11% 244±24%
ACh+L-Arg 96.3× 10−9 ± 16.8×10−9 32.0× 10−9 ± 10.2×10−9c 79± 6% 71± 4% 205± 22% 227±17%
ACh+L-NAME 12.1× 10−7 ± 35.1×10−8d 45.3× 10−10 ± 25.1×10−10 27± 7%d 26± 3%d 75± 17%d 69±9%d
ACh+L-Arg+L-NAME 28.9× 10−8 ± 22.2×10−8e 25.4× 10−9 ± 16.5×10−9 57± 6%e 40± 10% 210± 32%e 135±38%
18-WEEK-OLD
NA 19.2× 10−8 ± 49.3×10−9 24.3× 10−9 ± 78.1×10−10a* 2.6± 0.4N/gb 1.0± 0.1N/ga* 9.5± 1.6N/gb 4.5±0.7N/ga*
KCl 7.6± 1.5 67.8± 25.0a*,b* 1.8± 0.3N/gb 1.4± 0.2N/g 1.5± 0.2N/gb 0.9±0.1N/g
ACh 10.2× 10−7 ± 38.2×10−8b 57.6× 10−9 ± 24.3×10−9a* 96± 2% 57± 9%a*,b* 210± 20% 160±20%
SNP 10.0× 10−9 ± 81.7×10−11 68.6× 10−10 ± 14.5×10−10 95± 3% 70± 9%a*,b* 232± 12% 174±20%b*
ACh+L-Arg 21.1× 10−8 ± 16.0×10−8c 52.8× 10−9 ± 25.8×10−9 82± 6% 75± 3% 271± 29% 252±17%c
ACh+L-NAME 26.8× 10−7 ± 22.5×10−7 53.7× 10−11 ± 16.6×10−11 50± 6%b,d 32± 5%d 113± 19%d 100±24%
ACh+L-Arg+L-NAME 12.0× 10−8 ± 59.2×10−9 82.6× 10−9 ± 34.9×10−9 75± 4%e 40± 7%a* 238± 29%e 140±28%
Results were evaluated by Two–Way ANOVA followed by Bonferroni post-hoc analysis. Results are expressed as mean ± SEM.
aP < 0.05 between 12 weeks Lewis and LPK.
a*P < 0.05 between 18 weeks Lewis and LPK.
bP < 0.05 between 12 and 18 weeks Lewis.
b*P < 0.05 between 12 and 18 weeks LPK.
cP < 0.05 treatment effect within strain and age (ACh vs. L-Arg).
dP < 0.05 treatment effect within strain and age (ACh vs. L-NAME).
eP < 0.05 treatment effect within strain and age (L-NAME vs. L-Arg + L-NAME).
NA, noradrenaline; ACh, acetylcholine; SNP, sodium nitroprusside; L-Arg, L-arginine; L-NAME, Nω-nitro-L-arginine methyl ester; EC50, effective concentration at 50%; Rmax , maximum
response; AUC, area under the curve; LPK, Lewis polycystic kidney rat.
Vascular Aortic Nitric Oxide Synthase
Functionality
(1) L-Arg: ACh-mediated relaxation was slightly blunted in the
12-week-old Lewis when aortic rings were preincubated with
L-Arg (Figure 3A) but this was not accompanied by any
significant differences in EC50, Rmax or AUC (Table 3). By
contrast, in the 18-week-old Lewis, L-Arg shifted the ACh
concentration response curve to the left (Figure 3C) with a
significantly lower EC50. In the LPK, addition of L-Arg to the
organ bath at 12 weeks resulted in a smaller EC50 measure
relative to responses with ACh alone (Table 3). At 18 weeks
in the LPK animals, the addition of the NOS substrate did not
alter the EC50 but did result in a greater AUC compared with
responses in the presence of ACh alone (Figure 3D,Table 3).
(2) L-NAME: L-NAME markedly blunted the ACh-mediated
responses in all groups (Figures 3A–D), Rmax was lower in
the presence of L-NAME than in the presence of ACh alone
at all strains and ages (Table 3). AUC was also significantly
lower at all ages and strains other than LPK rats at 18 weeks
(Table 3).
(3) L-Arg and L-NAME: The combination of both NOS
substrate and inhibitor in the organ chamber attenuated
NOS inhibition and shifted the ACh concentration-
response curve downward toward greater recovery
of the vasorelaxation except in the 18-week-old LPK
(Figures 3A–D). This resulted in a reduction in the ACh
EC50 of the young Lewis and increase in the Rmax and AUC
values of both 12- and 18-week-old Lewis (Table 3), but this
was not reflected in the results for the LPK of either age.
The NO-dependent component of ACh-mediated relaxation was
significantly reduced in the aged LPK relative to both 18-week-
old Lewis and younger LPK (Figure 3E).
Mean values for plasma creatinine and urea for this cohort of
animals [cohort (i)] was as follows: creatinine (Lewis 12 weeks
27.1 ± 0.3, Lewis 18 weeks 27.4 ± 1.5, LPK 12 weeks 66.4 ± 2.7,
LPK 18 weeks 123.0 ± 5.0µmol/L) and urea (Lewis 12 weeks
6.2 ± 0.5, Lewis 18 weeks 7.7 ± 0.3, LPK 12 weeks 29.5 ±
1.0, LPK 18 weeks 43.6 ± 0.9mmol/L) and both parameters
showed the same age and strain effects as for the animal cohort
presented in Table 2, being elevated in the LPK compared with
age-matched Lewis, and an age-dependent increase for both urea
and creatinine occurring within the LPK strain.
Plasma Nitric Oxide and Vascular Aortic
Calcification
Plasma levels of NO−2 , NO
−
3 and total NO did not significantly
differ between Lewis and LPK and measures did not change
with age (Table 4). Thoracic aortic calcium content however was
markedly increased in the LPK vs. Lewis animals, and there was
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FIGURE 2 | Aortic relaxation responses in vessels precontracted with
1µM phenylephrine (PE) to cumulative additions of (A) acetylcholine
(ACh), (B) sodium nitroprusside (SNP), examining
endothelium-dependent and -independent relaxations, respectively.
The Lewis polycystic kidney (LPK) rats show impaired
endothelium-dependent and -independent relaxations at both ages.
P < 0.05 Lewis vs. LPK at (a) 12 weeks of age and (a*) 18 weeks of age.
P < 0.05 for age effect in (b) Lewis and (b*) LPK.
an age-dependent increase in aortic calcium observed in both
strains (Table 4).
Vascular Aortic Quantitative Polymerase Chain
Reaction mRNA Expression
The 1Ct values for each age and strain for the respective genes
are provided in Table 5. Preliminary statistical analysis of strain
and treatment effects was used to determine which specific
groups were compared for reporting as fold variation [2−(11Ct)]
(Livak and Schmittgen, 2001). Chosen reference groups were
(i) Lewis (both age groups combined) when assessing strain
only effect; (ii) 12-week-old data (both strains combined) when
assessing age only effect, (iii) 12-week-old Lewis (when assessing
both a strain and age effect).
Fold variation data is presented in Figure 4. Collagen I
expression showed a significant strain effect, but no age effect,
being greater overall in LPK aorta (Figure 4A). Collagen
III expression showed a significant age and strain effect,
being significantly increased in the 18-week-old LPK animals
(Figure 4B). Collagen III was also influenced by gender, with 18-
week-old male LPK animals having higher collagen levels than
18-week-old female LPK. Fibronectin levels were significantly
influenced by strain, being greater in the LPK animals
(Figure 4A). While there was no age effect, there was a strain x
age interaction (P = 0.01) which was the result of 10-fold higher
levels of fibronectin mRNA in 18-week-old LPK vs. 18-week-old
Lewis. Inducible NOS (iNOS) and endothelial NOS (eNOS) levels
were not significantly different between groups (Figure 4A).
Superoxide dismutase (SOD) gene expression did not show a
strain effect (Figure 4A) but there was an age effect, being
increased in the 18-week-old animals overall (fold difference 12-
week-old animals: 1.0 ± 0.1 vs. 18-week-old animals 3.1 ± 0.3).
Expression levels of mRNA for the NADPH oxidase subunit p47
(phox) showed significant strain and age effects due to higher
levels of p47 (phox) mRNA in the 18-week-old LPK animals
(Figure 4B).
Discussion
The incidence of cardiovascular disease is markedly increased
in patients with advanced kidney disease and is associated
with changes in vascular function (Sutliff et al., 2011). We
have previously shown that the thoracic aorta from the LPK
rodent model of CKD exhibits significant remodeling (Ng
et al., 2011; Ameer et al., 2014) and in this study we aimed
to determine if aortic vascular functional responses declined
in parallel with measures of renal dysfunction and examined
potential underlying mechanisms. We show that aortic vessel
responses are altered in the LPK model of CKD, and that a
temporal deterioration in function is present, manifesting as
endothelium-dependent and -independent deficits that associate
with markers of advancing CKD. We provide evidence that the
LPK rat aorta exhibits a significant reduction in its ability to
contract or relax in an in-vitro experimental paradigm, displays
increased sensitivity to a sympathetic agonist, functional loss
of NOS activity, a progressive increase in aortic calcification,
increased expression of mRNA for the fibrosis markers collagen
I, III and fibronectin, and increased mRNA levels of the NADPH
p47 (phox) subunit, an indicator of increased oxidative stress.
Altered aortic responsiveness to vasoconstrictors and
impairments of the vessel contractile capacity were apparent
and progressive in nature in LPK rats. Studies investigating the
effect of renal failure on aortic reactivity to vasoconstriction
stimuli have proven disparate, with some studies showing
reduced responsiveness and others showing enhanced responses
(Rascher et al., 1982; Zimlichman et al., 1984; Meggs et al.,
1986; Sutliff et al., 2011). In this study, we were able to show
that a combination of both defects exist in the LPK, whereby
adrenergic-mediated vasoconstriction is more sensitive in the
LPK, as indicated by reduced EC50 measures; however maximal
responses to NA and high K+ were not attainable, reflected in
the blunted Rmax and AUC in the LPK.
The hypersensitivity to sympathetic pressors that we observe
in this study may be related to deficiency of vasodilators such as
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FIGURE 3 | Panels illustrate aortic relaxation responses in vessels
precontracted with 1µM phenylephrine (PE) to cumulative addition
of acetylcholine (ACh) in (A) 12 week old Lewis, (B) 12-week-old
Lewis polycystic kidney (LPK) rats, (C) 18-week-old Lewis, and
(D) 18-week-old LPK. Panels illustrate control (ACh only) and ACh
responses in the presence of L-arginine (L-Arg, 10mM),
Nω-nitro-L-arginine methyl ester (L-NAME, 10µM) or both.
Percentage (%) relaxation was determined as % inhibition of PE contraction.
(E) illustrates overall nitric oxide (NO)-dependent component of ACh-induced
relaxation, calculated as the difference in Rmax response to ACh before
and after incubation with L-NAME. Results are expressed as mean ±
SEM. (a*) P < 0.05 Lewis vs. LPK at 18 weeks of age, (b*) P < 0.05 for
age effect in LPK. (c) P < 0.05 treatment effect within strain and age
(ACh vs. L-Arg), (d) P < 0.05 treatment effect within strain and age (ACh
vs. L-NAME), (e) P < 0.05 treatment effect within strain and age (L-NAME
vs. L-Arg + L-NAME).
NO (Chang and Stevens, 1992), prostacyclin or kinins, vascular
structural alterations secondary to pre-existing hypertension,
or retention of uraemic toxins (Beretta-Piccoli et al., 1982).
Intriguingly, heightened sensitivity to the sympathetic agonist
in the LPK was not associated with similar increases in
the sensitivity to muscle depolarization with high K+. This
contrasts with reports in the adenine-induced renal failure
model, where renal failure induced by adenine consumption
combined with dietary modifications to markedly accelerate
vascular calcification resulted in increased sensitivity to the
depolarizing signals of high K+, yet unaltered sensitivity to α-
adrenergic stimuli (Sutliff et al., 2011). This dissimilarity may be
due to the acute time course over which severe kidney failure and
vascular calcification was achieved in the adenine model, which
as noted by the authors, prevented remodeling of the vessel wall
that would otherwise occur in a more naturally progressive form
of CKD (Sutliff et al., 2011).
In the LPK, maximal impairment of adrenergic
vasoconstriction was attained early during the course of
CKD, while high K+ induced vasoconstriction declined further
with age. An age related decline in aortic compliance was also
seen in the Lewis animals, and in both strains we saw progressive
vascular calcification, with greater calcium levels in the LPK
animals at both time points. This is consistent with previously
described negative associations between arterial compliance and
magnitude of vascular calcification (Niederhoffer et al., 1997;
Sutliff et al., 2011) and substantiates aortic calcification as a
feature of both arterial aging (Cecelja and Chowienczyk, 2012)
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and the underlying pathology of CKD (Sarnak et al., 2003).
Changes in the structural components that make up the vessel
wall are also believed to be an important mechanism underlying
arterial stiffness (Zieman et al., 2005) and our demonstration
of higher mRNA levels of collagen I, III and fibronectin in the
current study support this premise, consistent with our previous
findings of both vascular remodeling and increased pulse wave
velocity in the LPK rodents (Ng et al., 2011). In this study, we
also show that the LPK rats exhibited cardiac and left ventricular
hypertrophy. As cardiac ventricles and the arterial tree constitute
a coupled biological system (Munoz and Sacco, 1997), these
cardiac remodeling changes could be linked to the demonstrated
alteration in aortic compliance and its influence on blood
pressure wave state, both of which increase cardiac work load,
and consequently cause the heart to adapt by remodeling (Chen,
2012).
In addition to stable components that make up the vessel
wall, arterial stiffness can also be substantially influenced by
dynamic factors such as endothelial cell signaling (Zieman et al.,
2005). Data from the present study indicate an inability of
the LPK rodent aortic tissue to achieve a maximal relaxation
TABLE 4 | Plasma nitrite, nitrate, total NO levels and calcium aortic
content in 12- and 18-week-old Lewis and LPK rats.
Parameter 12-week-old 18-week-old
Lewis LPK Lewis LPK
NO−2 (µM) 32.7± 6.4 27.3±6.5 25.4± 4.5 22.9± 4.9
NO−3 (µM) 145.6± 25.7 206.3±24.8 208.3± 15.8 230.8± 16.8
Total NO (µM) 178.3± 20.8 233.6±21.1 233.6± 16.8 253.7± 16.8
Aortic Ca content
(µmol/g)
24.3± 4.3 39.5±4.9a 40.5± 1.9b 57.5± 3.4a*,b*
Results are expressed as mean ± SEM. Results were evaluated by Two–Way ANOVA
followed by Bonferroni post-hoc analysis.
aP < 0.05 between 12 weeks Lewis and LPK.
a*P < 0.05 between 18 weeks Lewis and LPK.
bP < 0.05 between 12 and 18 weeks Lewis.
b*P < 0.05 between 12 and 18 weeks LPK.
NO−2 , nitrite; NO
−
3 , nitrate; NO, nitric oxide; Ca, calcium; LPK, Lewis polycystic kidney.
response under in-vitro conditions, and there was evidence of
endothelial cell dysfunction, with impaired aortic vasodilator
responses to ACh, which progressed in severity as the renal
function declined. Endothelium-independent vasodilation, as
elicited by the action of SNP on vascular smooth muscle was
also impaired, and similarly deteriorated with age. Impaired
endothelium-dependent and independent relaxations have been
reported in a number of animal models (Wang et al., 1999;
Karavalakis et al., 2008; Sutliff et al., 2011) and humans (Hand
et al., 1998; Morris et al., 2001) with renal disease. Importantly,
our observation of a decline in endothelium-dependent and-
independent relaxations in parallel with the deterioration of renal
function supports the hypothesis that systemic uraemic toxins
can cause vascular damage and inflammation, leading to altered
vascular function in CKD (Himmelfarb et al., 2002). The reduced
capacity of the LPK aorta to relax is moreover consistent with a
loss of arterial compliance, likely impacted by aortic calcification
and stiffness as discussed above.
Our work and that of other indicates that ACh-mediated
relaxation of large arteries from normotensive rodent aorta is
predominantly mediated by NO (Spradley et al., 2013; Tanaka
et al., 2015). Accordingly, our protocol involved studying the
response of the aortic rings to ACh following preincubation
with the NOS precursor L-Arg and the NOS inhibitor L-
NAME. Our results show that L-Arg was able to improve the
sensitivity to ACh-mediated relaxation in the 12-week-old LPK,
as indicated by a lower EC50 in response to NOS substrate,
and at 18 weeks of age in the LPK, L-Arg increased the AUC
of ACh-mediated relaxation, noting however, this effect was
not replicated in the EC50 data. Our data does therefore not
support defects in the uptake of the precursor L-Arg through
the endothelial cationic transporter (Schiffrin et al., 2007) as
being a moderating mechanism of endothelial dysfunction in the
LPK model. Interestingly however, we also observed aging effect
in the Lewis animals, with a decrease in ACh sensitivity that
was improved after L-Arg treatment in the older animals. These
results suggest potential age and renal effects over ACh sensitivity
that will benefit from future evaluation with L-Arg dose response
curves.
TABLE 5 | 1Ct values for aortic mRNA gene expression in 12- and 18-week-old Lewis and LPK rats.
mRNA gene expression 12-week-old 18-week-old Two-Way ANOVA adjusted P-value
(1Ct) Lewis LPK Lewis LPK Strain Age
Collagen I −2.58± 0.66 −3.54±0.13 −2.22± 0.22 −4.06± 0.78 0.009 0.854
Collagen III −2.52± 0.49 −2.61±0.11 −2.59± 0.04 −4.40± 0.73 0.029§ 0.031
Fibronectin 0.08± 0.78 −0.13±0.40 1.93± 0.26 −1.43± 0.35 0.005 0.606
eNOS 3.02± 0.37 2.97±0.02 2.97± 0.30 2.13± 0.37 0.163 0.167
iNOS 5.91± 0.28 5.01±0.40 5.08± 0.76 4.79± 0.20 0.223 0.286
SOD −2.23± 0.20 −2.22±0.27 −3.83± 0.26 −3.9± 0.11 0.899 <0.001
p47 (phox) 4.26± 0.32 3.97±0.19 4.53± 0.30 1.84± 0.28 <0.001 0.006
1 cycle threshold (1Ct) values representing threshold PCR cycle number normalized to endogenous control gene YWHAZ, with a lower number representing a higher level of expression.
Results are expressed as mean ± SEM. Results were evaluated by Two–Way ANOVA followed by Bonferroni post-hoc analysis.
§ Indicates significant gender effect. LPK, Lewis polycystic kidney; eNOS, endothelial nitric oxide synthase; iNOS, inducible NOS; p47 (phox), NADPH oxidase subunit p47 (phox); SOD,
superoxide dismutase.
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FIGURE 4 | Relative gene expression levels for aortic markers of
fibrosis, NO synthesis and oxidative stress. Gene expression was
normalized to YWHAZ as an endogenous control and then 1Ct values
compared for significant differences between ages and strain (Table 5). Figure
presents fold variation and range values for selected results for (A) strain
effect, with data expressed relative to Lewis (both age groups combined) and
(B) strain and age effect, with data expressed relative to 12-week-old Lewis.
*Significant difference (P < 0.05) between (A) LPK and Lewis controls or (B)
LPK 18-week-old animals and all other groups. LPK, Lewis polycystic kidney;
eNOS, endothelial nitric oxide synthase; iNOS, inducible NOS; p47 (phox),
NADPH oxidase subunit p47 (phox); SOD, superoxide dismutase.
Data from the present study showed that L-NAME attenuated
the ACh-mediated relaxation in both strains; however, this was
not associated with marked reductions in the AUC of the aged
LPK relative to their AUC response in the absence of L-NAME,
consistent with a progressive loss in functional NOS activity
and therefore impaired NOS-mediated relaxation. Combination
of the NOS substrate with the inhibitor, which assessed the
relative sensitivity of NOS to both agents, revealed that NOS
was able to compensate for the loss of function induced by
the inhibitor in the young LPK but not in the older LPK.
This indicates that the older LPK, with more progressed renal
dysfunction, are hypersensitive to the enzyme inhibitor and
recovery of any existing dysfunction of NOS was unattainable
when disease reaches an advanced stage. This view is supported
by the finding that the NO-dependent component of ACh-
mediated relaxation temporally declined in the LPK. There were
no differences in aortic eNOS mRNA expression levels, however
we did not measure protein levels and the possibility that eNOS
could be present in an inactive formwarrants future investigation
(Peterson et al., 2013). Future in-vitro studies which directly
measure aortic NOS bioactivity and levels of both eNOS and the
phosphorylation of serine 1177 of eNOS, reflecting the activated
form of the protein (Boo et al., 2002) will greatly inform our
overall understanding of the mechanisms driving changes in NO
bioavailability and NOS sensitivity in large vessels associated with
kidney disease. It has also been proposed that lack of compliance
may contribute to a decrease in NOS activity, feeding into a
negative cycle whereby structural changes further contribute to
arterial stiffness (Zieman et al., 2005).
Systemic NO levels were not altered in this study, with no
difference between groups in the plasma measures of NO−2 , NO
−
3
and total NO. This is consistent with findings in the Han:SPRD
Cy polycystic kidney disease rat model (Wang et al., 1999),
however additional factors, including the contribution of other
vascular beds will also influence systemic NO levels.
Endothelial dysfunction can alternatively arise from altered
downstream responses to NO. Our data indicated a reduced
sensitivity to the NO donor SNP in the young LPK animals,
and an age effect was also evident, with 18-week-old LPK
demonstrating reduced maximal relaxations. These data
suggest that impaired NO/cGMP signaling, independent of NO
production or bioavailability per se, may be a contributing factor
to the observed decline in vasorelaxation responses in the LPK
animals. Whether this is due to changes in the activity of soluble
guanylate cyclase and/or levels of cGMP is yet to be established,
however such mechanisms have recently been proposed to
contribute to reduced vascular relaxation in obesity (Neves et al.,
2014).
Vasodilation can be induced by ACh via mechanisms other
than NOS activity, such as the release of prostaglandin and
endothelial-derived hyperpolarizing factors which are resistant to
the blocking effect of L-NAME (Kato et al., 1990; Wang et al.,
2008; Giles et al., 2012). These pathways were not examined
in the current study and specific tests to ascertain how their
contribution was altered in the diseased state will be required.
Another pathway that could predispose to endothelial
dysfunction is oxidative stress (Schiffrin et al., 2007). Various
factors can stimulate NADPH oxidase (Schiffrin et al., 2007),
leading to the generation of superoxide anion and thus
contributing to endothelial dysfunction and vascular remodeling
during hypertension (Touyz and Schiffrin, 2004). This is
consistent with our findings of increased expression of the
NADPH subunit p47 (phox) in the aorta of 18-week-old LPK
animals. Our data has also shown an increase in the antioxidant
SOD with aging. This was irrespective of strain and could be
interpreted as a counter-regulatory mechanism that promotes a
reduction in oxidative stress in the face of the vascular aging
process, as has been previously documented (Guo et al., 2001).
Future work that obtains direct estimates of both NADPH
oxidase protein levels and SOD activity (Ding et al., 2012), as
well as measures of vascular superoxide production (Tanaka
et al., 2015) will provide a more complete understanding of the
disease process, as will studies that seek to reverse or alleviate
components of the vascular dysfunction that we have identified.
Reduced compliance of large arterial vessels in CKD patients
has significant clinical implications, and our observation of
multiple vascular structural and functional abnormalities in
the LPK rodent model highlight the complex interaction of
uraemia with the vasculature. Increased aortic stiffness, altered
sensitivity to vasoconstrictor agents, impaired endothelium-
dependent and –independent relaxation responses, and impaired
NOS-mediated relaxation are all factors that could ultimately
contribute to the transmission of greater pulsatile pressures and
increased risk of end organ damage (Briet et al., 2011) and as such
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should therefore be considered important therapeutic targets to
reduce cardiovascular risk in CKD.
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